Eledon Pharmaceuticals logo

Eledon Pharmaceuticals Share Price Today

(NASDAQ: ELDN)

Eledon Pharmaceuticals share price is $3.94 & ₹342.66 as on 6 Mar 2025, 2.30 'hrs' IST

$3.94

0.05

(1.29%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Eledon Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Eledon Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Eledon Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Eledon Pharmaceuticals share price movements

  • Today's Low: $3.82
    Today's High: $4.02

    Day's Volatility :4.98%

  • 52 Weeks Low: $1.52
    52 Weeks High: $5.54

    52 Weeks Volatility :72.56%

Eledon Pharmaceuticals (ELDN) Returns

PeriodEledon Pharmaceuticals IncIndex (Russel 2000)
3 Months
-10.78%
0.0%
6 Months
51.36%
0.0%
1 Year
127.49%
0.0%
3 Years
16.82%
-11.6%

Eledon Pharmaceuticals (ELDN) Key Statistics

in dollars & INR

Previous Close
$3.89
Open
$3.88
Today's High
$4.02
Today's Low
$3.82
Market Capitalization
$247.9M
Today's Volume
$62.7K
52 Week High
$5.54
52 Week Low
$1.5199
Revenue TTM
$0.0
EBITDA
$-36.9M
Earnings Per Share (EPS)
$0.71
PE Ratio
5.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-25.89%

How to invest in Eledon Pharmaceuticals Stock (ELDN) from India?

It is very easy for Indian residents to invest directly in Eledon Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eledon Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eledon Pharmaceuticals or ELDN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eledon Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eledon Pharmaceuticals shares which would translate to 0.221 fractional shares of Eledon Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Eledon Pharmaceuticals, in just a few clicks!

Returns in Eledon Pharmaceuticals (ELDN) for Indian investors in Rupees

The Eledon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eledon Pharmaceuticals investment value today

Current value as on today

₹2,35,358

Returns

₹1,35,358

(+135.36%)

Returns from Eledon Pharmaceuticals Stock

₹1,30,409 (+130.41%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Eledon Pharmaceuticals (ELDN)

-43%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Eledon Pharmaceuticals Stock from India on INDmoney has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Eledon Pharmaceuticals

  • Bvf Inc

    10.53%

  • RA Capital Management, LLC

    5.97%

  • Vanguard Group Inc

    4.85%

  • Sphera Funds Management Ltd.

    4.27%

  • First Light Asset Management, LLC

    3.90%

  • Blue Owl Capital Holdings LP

    3.28%

Analyst Recommendation on Eledon Pharmaceuticals

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Eledon Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Eledon Pharmaceuticals Stock (ELDN)

What analysts predicted

Upside of 163.96%

Target:

$10.40

Current:

$3.94

Insights on Eledon Pharmaceuticals Stock (Ticker Symbol: ELDN)

  • Price Movement

    In the last 6 months, ELDN stock has moved up by 53.1%
  • ELDN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 30.2%

Eledon Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Eledon Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Eledon Pharmaceuticals (ELDN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Eledon Pharmaceuticals Inc logo
-16.7%
51.36%
127.49%
16.82%
-74.24%
Regeneron Pharmaceuticals, Inc. logo
-3.09%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.43%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
0.82%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-10.36%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Eledon Pharmaceuticals Inc logo
5.64
5.64
NA
-1.05
-0.26
-0.33
NA
1.85
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Eledon Pharmaceuticals Inc logo
Buy
$247.9M
-74.24%
5.64
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Eledon Pharmaceuticals

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for kidney transplantation, xenotransplantation, and liver transplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Organization
Eledon Pharmaceuticals
Employees
20
CEO
Dr. David-Alexandre C. Gros M.D., Ph.D.
Industry
Miscellaneous

Management People of Eledon Pharmaceuticals

NameTitle
Dr. David-Alexandre C. Gros M.D., Ph.D.
CEO & Non Independent Director
Dr. Steven N. Perrin Ph.D.
President, Chief Scientific Officer & Non Independent Director
Mr. Paul Sean Little
Chief Financial Officer
Mr. Bryan E. Smith J.D.
General Counsel, Corporate Secretary & Chief Compliance Officer
Dr. David Hovland Ph.D.
Chief Regulatory Officer
Mr. John Herberger
Vice President of Technical Operations
Dr. Eliezer Katz F.A.C.S., FACS, M.D.
Chief Medical Officer

Important FAQs about investing in ELDN Stock from India :

What is Eledon Pharmaceuticals share price today?

Eledon Pharmaceuticals share price today stands at $3.94, Open: $3.88 ; Previous Close: $3.89 ; High: $4.02 ; Low: $3.82 ; 52 Week High: $5.54 ; 52 Week Low: $1.52.

The stock opens at $3.88, after a previous close of $3.89. The stock reached a daily high of $4.02 and a low of $3.82, with a 52-week high of $5.54 and a 52-week low of $1.52.

Can Indians buy Eledon Pharmaceuticals shares?

Yes, Indians can invest in the Eledon Pharmaceuticals (ELDN) from India.

With INDmoney, you can buy Eledon Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Eledon Pharmaceuticals at zero transaction cost.

How can I buy Eledon Pharmaceuticals shares from India?

It is very easy to buy Eledon Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eledon Pharmaceuticals (ELDN) be purchased?

Yes, you can buy fractional shares of Eledon Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Eledon Pharmaceuticals stocks?

To start investing in Eledon Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Eledon Pharmaceuticals Stock (ELDN)?

Today’s highest price of Eledon Pharmaceuticals (ELDN) is $4.02.

Today’s lowest price of Eledon Pharmaceuticals (ELDN) is $3.82.

What is today's market capitalisation of Eledon Pharmaceuticals?

Today's market capitalisation of Eledon Pharmaceuticals ELDN is 247.9M

What is the 52 Week High and Low Range of Eledon Pharmaceuticals Stock (ELDN)?

  • 52 Week High

    $5.54

  • 52 Week Low

    $1.52

What are the historical returns of Eledon Pharmaceuticals (ELDN)?

  • 1 Month Returns

    -16.7%

  • 3 Months Returns

    51.36%

  • 1 Year Returns

    127.49%

  • 5 Years Returns

    -74.24%

Who is the Chief Executive Officer (CEO) of Eledon Pharmaceuticals ?

Dr. David-Alexandre C. Gros M.D., Ph.D. is the current Chief Executive Officer (CEO) of Eledon Pharmaceuticals.